Market Research Reports

Sunday 22 November 2020

Drug Infusion System Market Opportunities, Sales, Cost and Profit

Global Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Global Forecast Till 2023

Key Players

Some of the key players for the global drug infusion system market are Medtronic, Arcomed AG, B. Braun Melsungen AG, Baxter, Becton Dickinson and Company, Debiotech S.A., Fresenius SE & Co. KGaA, Halyard Health, Inc, ICU Medical Inc, IRadimed Corporation, Insulet Corporation, Terumo Corporation, Smiths Group plc, Tandem Diabetes care, MOOG INC., and others.

Market Highlights

The increase in the prevalence of chronic diseases such as cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. Furthermore, adoption of technologically advanced devices and the rising geriatric population are the key factors for the market to grow. However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/6207

Regional Analysis

The Americas dominated the global drug infusion system market in 2017. This can be attributed due to the rising incidence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis within the region provides favorable backgrounds for market growth. According to the American Heart Association (2018), 92.1 million Americans suffer from some form of the cardiovascular disease. Also, the presence of major market players such as Medtronic and Becton, Dickinson and Company within the region influences the market growth.

Europe (the UK, Belgium, France & Netherlands) is second in the market owing to increasing healthcare expenditure, and rising prevalence of chronic respiratory diseases is expected to influence the market in this region. According to Eurostat in 2014, 382 thousand deaths were due to chronic respiratory diseases in the European Union (EU). Thus, the rise in chronic respiratory diseases favors the growth of the market in this region.

Asia Pacific is expected to observe the fastest growth for the global Drug infusion system market owing to a growing geriatric population in this region. The Asian Development Bank (ADB) projected that in 2050 the geriatric population is expected to reach 923 million. This offers potential growth opportunities in this region.

Segmentation

The global drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, is sub-segmented into Elastomeric infusion system, Disposable infusion system, Syringe infusion system, Peristaltic pump, Multi-channel pump, Patient-controlled analgesia (PCA) pump, Insulin pump and Implantable infusion system.

On the basis of Application, the market is categorized into Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, and others. Mode of administration is further sub-segmented into Intravenous, Subcutaneous, Arterial, Epidural and Others. By end-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic centers and others.

Brows More Healthcare Related Research Reports:

Micropump Market by Share, Size, Growth and Analysis – 2024 | MRFR

Mastitis Market by Type, Share, Growth and Analysis – 2023 | MRFR

Percutaneous Coronary Intervention Market by Growth and Forecast – 2023 | MRFR

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Nanobots Market Landscape, Key Companies Profile and Solutions

Global Nanobots/Nanorobots Market: Information by Product Type (Nanomanipulator, Bio-Nanorobotics, Magnetically Guided Nanobots/Nanorobots), Application (NanoMedicine, Biomedical), Region (Americas, Europe, Asia-Pacific and the Rest of the World) - Forecast till 2025

Detailed Regional Analysis

The regional analysis of the nanobots market comprises of regions such as Asia Pacific, North America, Europe, the Middle East, and Africa. The North American region is the principal market for nanobots. The North American regional market for nanobots is projected to develop at a CAGR of 12.2% and is projected to attain USD 73 billion from USD 55 billion in 2016 by the conclusion of the forecast period. The awareness related to the use of nanobots for surgical care and treatment of patient’s factor is driving the market in the North American region. The European region is the second chief market for nanobots. Whereas, the Asia Pacific region is projected to be the fastest increasing market for nanobots. India is likely to flourish progressively in this market as the application of this technology entails a large amount of financial investment by the healthcare organizations and also enhanced training for the staff. Most of the hospitals are primarily focusing on providing primary healthcare to patients. The market also shows solid growth in the Middle East and African region.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/1301

Competitive Analysis

The decrease in trade restrictions is anticipated to create favorable opportunities for development in the forecast period. The presence of favorable trade policies is anticipated to improve the growth of the nanobots market in the impending period. Strong insights into the market’s condition are motivating the expansion of the forecast period. The offering in the market has also diversified considerably ensuring availability of better-quality products in the market. Amplified investment in the market is likely to motivate the positive changes in the market in the forecast period. The emergence of specialization in production has also increasingly improved the growth trajectory of the market. The efficiencies achieved in the allocation of resources is expected to encourage the development of the market in the approaching period. Moreover, increased cost efficiencies are projected to positively impact the progress of the market in the coming years.

The notable players functioning in the nanobots market are Zymergen Inc. (U.S), Ginkgo Bioworks (U.S), Synthace Limited (U.K), Advanced Diamond Technologies (U.S), Xidex Corp. (Texas), and Advanced Nano Products Co Limited (South Korea) to name a few.

Industry Updates:

A team has planned on using nanobots to generate the ‘internet of thoughts,’ where prompt knowledge could be transferred just by thinking it. A global team of scientists led by associates of the US Institute for Molecular Manufacturing and UC Berkeley predicts that exponential development in nanomedicine, nanotechnology, artificial intelligence (AI) and computation will direct this century to the expansion of a human ‘brain-cloud interface’ (B-CI).

Segmental Analysis

The segmental assessment of the nanobots market has been carried out on the basis of type, application, and region. On the basis of type, the nanorobots market is segmented into respirocyte nanorobots, microbivore nanorobots, clottocyte nanorobots, and cellular repair nanorobots. The other types of nanobots are bacteria-powered robots and nanoswimmers. Based on the application, the nanobots market is segmented into biomedical, nano medicine, mechanical, and other applications. Based on the region, the nanobot market is segmented into North America, Asia Pacific, Europe, the Middle East, and Africa.

Overview

The pathbreaking developments in robotics are expected to create favorable demand for nanorobots. Reports that evaluate the medical device industry have been made accessible by Market Research Future, which creates reports on several industry verticals that review the market development and prospects. The nanobots market is projected to be motivated to attain USD 100 billion in earnings while flourishing at a CAGR of 21 % in the forecast period.

The use of nanorobots is drastically modifying the landscape for treatment delivery in the healthcare sector. The need to achieve reliable treatment results is anticipated to motivate the market for nanobots in the coming years. Increased understanding of the operation of nanobots is expected to lead to increased implementation, thus motivating the market for nanobots.

Brows More Healthcare Related Research Reports

Hematology Diagnostics Market Research Report –Global Forecast to 2023| MRFR

Aseptic Sampling Market Research Report –Global Forecast to 2023| MRFR

Odontogenic Tumor Market Research Report –Global Forecast to 2023| MRFR

Nystagmus Market SWOT Analysis, Demand and Emerging Trends

Nystagmus Market Share And Application By Type (Infantile, Latent Nystagmus, Noonan Syndrome, Nystagmus Blockage Syndrome) Diagnosis (Ct Scan, Mr Scan, Chromosome Analysis, Ultrasonography) Treatment (Medication, Surgical) End-User – Global Forecast Till 2023

Market Overview:

Increasing prevalence of rare diseases, rising demand for better treatment, increasing investment in biotechnology and pharmaceutical industries for R&D, and availability of funds are driving the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology is expected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth during the period, 2017-2023.

The global Nystagmus market is expected to grow at a CAGR of ~6.2 % during the forecast period 2017-2023. According to the Association for Research in Vision and Ophthalmology (2012), the prevalence of Nystagmus was estimated to be 24.0 per 10,000 population across the globe. The study identified the following as the most common forms of Nystagmus; neurologic Nystagmus (6.8 per 10,000 population), Nystagmus associated with low vision such as congenital cataracts (4.2 per 10,000), and Nystagmus associated with retinal diseases

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/5441

Segmentation:

The Nystagmus market is segmented on the basis of type, diagnosis, treatment, and end-users.

Based on the type, the market is segmented into infantile, latent nystagmus, noonan syndrome, and nystagmus blockage syndrome.

On the basis of the diagnosis, the market is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others.

On the basis of the treatment, the market is segmented into medications, surgical, and others.

On the basis of the end-user, the market is segmented into hospitals & clinics, research centers, specialty eye clinics, and others.

Regional Analysis:

The Americas dominate the global Nystagmus market owing to the presence of a huge patient population with eye problem, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global Nystagmus market as result of increasing focus of various government agencies on the treatment of eye diseases. Moreover, the growing public awareness about Nystagmus is likely to boost the European market.

The Asia Pacific region is expected to be the fastest growing region and is anticipated to compete with the American and European region during the forecasted period 2017-2023. Japan holds the major share of the regional market due to the availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development is projected to drive the market in China and India over the forecasted period.

The Middle East and Africa hold the least share of the global market due to limited availability of medical facilities. The U.A.E., Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.

Key Players:

Some of key the players in the global Nystagmus market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others.

Brows More Healthcare Related Research Reports:

Duloxetine Intermediate and Atorvastatin Intermediates Market by Forecast – 2023 | MRFR

Lancet and Pen Needles Market Trends Analysis, Growth | Size Value, 2027

Microfluidic Devices Market Size Analysis, Trends | Share Value, 2025

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Nystagmus Market SWOT Analysis, Demand and Emerging Trends

Meralgia Paresthetica Market Research Report: By Diagnosis (Imaging Techniques, Electromyography, Nerve Conduction Study, Nerve Blockade), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories) - Global Forecast till 2023

Segmentation

The global meralgia paresthetica market is segmented on the basis of types, by treatment, and by end user. On the basis of diagnosis it is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques is further segmented into X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others. Based on the treatment, it is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (dilantin) or pregabalin (lyrica) and others. On the basis of end user, it is segmented into hospitals & clinics, research laboratories, and others.

Key Players

Some of key the players in the meralgia paresthetica market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/5313

Regional Analysis

The Americas dominate the global meralgia paresthetica market owing to the presence of huge patient population with obesity and diabetes, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global meralgia paresthetica market as result of increasing focus of various government agencies on the treatment of chronic diseases. Moreover, the growing public awareness about meralgia paresthetica likely to boost the European market.

Asia Pacific is the fastest growing meralgia paresthetica market across the globe. Japan holds the major share of the regional market due to availability of advanced technology and huge healthcare spending. Moreover, rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development projected to drive the market in China and India over the forecasted period.

The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth

Market Overview

The global meralgia paresthetica market is expected to grow at a CAGR of ~7.9 % during the forecast period 2017-2023. According to Obesity Society, in the United States (2014), 28.1% of the total population was obese. Out of them, 33.7% were men and 36.5% were women. The prevalence of obesity for men and women aged 20-39 years was 39.5% and 35.4%, respectively. The obesity prevalence was higher in the South (29.4%) and Midwest (29.5%) and lower in the Northeast (25.3%) and West (25.1%) of Unites States.

During last decade the number of treatment procedures have increased which has influenced the growth of the market positively. Moreover, increasing number of patients suffering from chronic diseases have increased the demand different treatments in the market. The market is expecting a healthy growth during the next decade. Moreover, well developed technology has supported the growth of the market in this region.

Brows More Healthcare Related Research Reports:

Cardiac Rehabilitation Devices Market Size, Share Analysis | Growth, 2023

Home Infusion Therapy Devices Market by Type, Application and Analysis – 2024 | MRFR

Real Time Health Monitoring Devices Market Share Analysis, Size | Application, 2025

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com .

Calciphylaxis Treatment Market Investment Feasibility, Share, Demand

Calciphylaxis Market Information: By Diagnosis (Deep Skin Biopsies, Blood Tests and Imaging), Treatment, (Intensive Wound Care, Medication, Therapy, and Clot-Dissolving), End User (Hospitals, Clinics, Medical Research Centers) - Global Forecast till 2023

Major Players in the Calciphylaxis Market

Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.

The Global Calciphylaxis Market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023. Warfarin is an oral anticoagulant which inhibits the synthesis of vitamin K- dependent clotting factors.

Segmentation

The global Calciphylaxis Market is segmented on the basis of diagnosis, treatment, and end user. On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. The deep skin biopsies are further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others. On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. The medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates. On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.

Regional Analysis

Asia Pacific consists of Japan, China, India, Australia, Republic of Korea, and rest of Asia Pacific. Increasing incidence of chronic kidney failure across Asia Pacific. Moreover, the growth of this segment is attributed to high population growth, increasing environmental pollution, and urbanization. Increasing incidence of calciphylaxis, improving healthcare infrastructure and rising awareness about the treatment process have spurred the growth of Calciphylaxis Market in Asia Pacific region.

Europe consists of two regions namely Western Europe and Eastern Europe. Western Europe consists of countries namely Germany, the U.K., France, Italy, Spain, and Rest of Western Europe. Increasing prevalence of cardiovascular calcification in ESRD patients is a key driver for the growth of this market in Europe. Moreover, increasing healthcare expenditure, rising research & development activities, awareness among patients about the treatment options supporting the market growth for calciphylaxis.

The Americas account for a major share of the market owing to the presence of patient population, well-developed technology, high healthcare expenditure and the presence of the leading players. Moreover, due to the high prevalence of end stage renal diseases (ESRD) on of the major cause of calciphylaxis in U.S. As per The Regents of the University of California, the rate of ESRD is increasing in the U.S. by 5% per year. The American calciphylaxis market is expected to reach USD 1,257 million by 2023 from USD 581.9 million in 2016.

Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3567

On the other hand, the Middle East & Africa owns the minimum market share of the calciphylaxis market due to less development in the healthcare services such as new and advanced diagnosis & treatment methods in healthcare domain.

Market Highlights

These include bisphosphonates, newer non-calcium/non-aluminum-containing phosphate binders and case reports of use of cinacalcet. Other treatments for calcific uremic arteriolopathy (CUA) that are not targeted directly at calcium/phosphate homeostasis include HBOT and the sodium thiosulphate. The healthcare professionals have stated that randomized controlled trials for treatments in CUA are still lacking, which has restrained the growth of the market.

Warfarin is most commonly prescribed cardiovascular agent. However, excess use of anticoagulant increases the risk of calciphylaxis in treatment seeking population. According to the national pharmaceutical regulatory agency (2015), cases of calciphylaxis have been reported in patients on warfarin therapy. Although many of the cases reported for pre-existing renal disease.

A number options are available in the market for the treatment of calciphylaxis, which is associated with hypophosphatemia, and secondary hyperparathyroidism with chronic kidney disease. European Medicine Agency review concluded that there is reasonable possibility between calciphylaxis and use of warfarin. Taste the market data and market information presented through more than 144 market data tables and 34 figures spread over 152 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “calciphylaxis market research report–Global forecast till 2023.”

Brows More Healthcare Related Research Reports:

RF Microneedling market Research Report - Forecast to 2023 | MRFR

Eye Allergy Treatment Market Size, Application | Share Analysis, 2023

Healthcare Regulatory Affairs Outsourcing Market Share, Trends | Application and Growth Analysis, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 524/528, Amanora Chambers

Magarpatta Road, Hadapsar

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Eyelashes Enhancing Agents Market Insights, Emerging Trends and Landscape

Eyelashes Enhancing Agents Market

Eyelashes Enhancing Agents Market Application And Growth Analysis By Types, (Curling, Lengthening, Volumizing, And Others), Application (Repairing Damaged Eyelashes, Nourishing), Content (Bimatoprost, Lash-Building Serum, Skincare Ingredients) - Global Forecast Till 2023

Market Analysis

The global eyelashes enhancing agents market is expected to rise at a strong 5.83% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global eyelashes enhancing agents market is mainly driven by the growing prevalence of ocular conditions around the world, driven by the growing air pollution, among other factors. The growing attention paid by cosmetics manufacturers to the production of eyelashes enhancing agents is also likely to be a major driver for the market over the forecast period.

Eyelash enhancing serums are formulas that contain nutritive, strengthening, conditioning, and moisturizing components to deliver a comprehensive upgrade to the eyelashes. This important part of a person’s face has become all the more important with the rise of cosmetics. While eyelashes have always been a key part of a woman’s (and to a lesser extent, man’s) aesthetic getup, their conditioning and enhancement has now taken precedence thanks to the growing availability of a number of cosmetic products especially designed to enhance the eyelashes and add to their characteristics in a meaningful way.

The rising prevalence of diseases such as madarosis and blepharitis is likely to drive the eyelashes enhancing agents market over the forecast period. Cancer patients, especially breast cancer patients, often suffer from madarosis as a result of intensive radiotherapy procedures. As a result, the growing prevalence of cancer could also act as a key driver for the global eyelashes enhancing agents market over the forecast period.

A growth in the demand for natural ingredients in eyelashes enhancing formulations could emerge as a key determinant for the global eyelashes enhancing agents market over the forecast period. The demand for natural ingredients has been a feature of the overall medical sector in the last few years and could end up as an important factor for the eyelashes enhancing agents market over the forecast period as well.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/4862

Regional Analysis:

The global eyelashes enhancing agents market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas hold the dominant share in the global eyelashes enhancing agents market due to the widespread availability of advanced products in the region and the high disposable income of consumers in the region, which fuels a great desire to own the most advanced cosmetic products among female consumers. The Americas market is expected to rise to a valuation of USD 234.59 million by 2023.

On the other hand, Asia Pacific is likely to exhibit the fastest growth in the global eyelashes enhancing agents market over the forecast period. The Asia Pacific market is expected to grow at a CAGR of 6.26% over the forecast period due to the growing popularity of cosmetics products in the region’s developing economies.

Competitive Analysis:

Leading players in the global eyelashes enhancing agents market include Estee Lauder, Rodan & Fields LLC, Athena Cosmetics Inc., Beauty Essentials LLC, Grande Cosmetics LLC, Skin Research Laboratories, and Allergan plc.

In October 2018, Topix Pharmaceuticals launched Replenix PROLash, a new eyelash enhancing serum that uses the trademarked WideLash technology to strengthen and lengthen eyelashes.

Segmentation:

The global eyelashes enhancing agents market is segmented on the basis of types, application, and content.

On the basis of type, the eyelashes enhancing agents market is segmented into curling, lengthening, volumizing, and others. Curling is the fastest growing segment and is expected to exhibit a strong 6.15% CAGR over the forecast period.

On the basis of application, the eyelashes enhancing agents market is segmented into repairing damaged eyelashes, nourishing, and others. Repairing damaged eyelashes took up a majority share of 54% in the market in 2017 and is likely to remain in command over the forecast period.

On the basis of the content, the market is segmented into bimatoprost, lash-building serum, skincare ingredients, herbal remedy, isopropyl cloprostenate, enhancer serum, and others. The skincare ingredients segment is further sub-segmented into polypeptides, biotin, panthenol, and others.

3D Bioprinting Market Report - Forecast to 2023 | MRFR

Global and North America Organic and Natural Feminine Care Market Research Report - Forecast to 2023 | MRFR

Poultry Vaccines Market Size, Trends | Growth Analysis, 2023

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Perfusion Market Segmentation, SWOT Analysis and Dynamics

Perfusion Market Information, By Type (Cardiopulmonary Bypass, Isolated Limb Perfusion, & Others), By Application (Heart, Lung, & Others), By Device Type (Normothermic Machine Perfusion, & Others), By End User (Hospital, & Others) - Global Forecast Till 2023

Global Perfusion Market - Segments

The perfusion market analysis is segmented into five key dynamics for enhanced understanding.

By Type : Cardiopulmonary Bypass, Extracorporeal Membrane Oxygenation, and Isolated Limb Perfusion among others.

By Application : Lungs, Heart, Liver, and Kidneys among others.

By Device Type : Hypothermic Machine Perfusion and Normothermic Machine Perfusion among others.

By End User : Hospital, Specialty Clinics, Medical Research Centers, and Academic Institutes among others.

By Regions : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Global Perfusion Market - Competitive Analysis

Highly competitive, the perfusion market appears fragmented owing to the presence of several well-established market players. These players through strategic initiatives such as acquisition, partnership, expansion, product & technology launch, and collaboration, try to gain a competitive advantage and maintain their positions in the market. Huge investments are being transpired in the R&D to bring betterments in surgical procedures and to develop devices that are on a different level entirely compared to their competition.

Major Players

Medtronic (Ireland), Getinge AB (Sweden), LivaNova PLC (U.K.), XENIOS AG (Germany), Terumo Medical Corporation (Japan), Lifeline Scientific, Inc. (U.S.), Repligen Corporation (U.S.), XVIVO Perfusion (Sweden), Spectrum Laboratories, Inc. (U.S.), Harvard Bioscience, Inc. (U.S.), Merck KGaA (Germany), and Ala Science (U.S.) among others.

Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/888

Global Perfusion Market - Regional Analysis

North American region heading with the increasing number of organ transplant surgeries dominates the global perfusion market, accounting for the largest share. Moreover, factors such as technological advancement and high per capita healthcare expenditures are expected to spur the market growth in the region.

The U.S. and Canada led by the rising number of chronic diseases associated with lungs, heart, liver, and kidneys lead the perfusion market in North America. Furthermore, the growing number of heart and kidney bypass surgeries and the growing prevalence of coronary diseases alongside the rapid uptake of advanced technologies and devices in the surgical process drive the growth in the regional market.

The perfusion market in the European region accounts for the second-largest market, globally. The region witnesses the increasing number of kidney & heart bypass procedures. Factors such as the availability of specialty care services in hospitals & tertiary care centers alongside the rising prevalence of cardiovascular diseases and the increasing demand for the treatment options of cardiovascular diseases escalate the market growth in the region.

Furthermore, the increasing healthcare expenditures led by the resurging economy in the region and spreading awareness towards bypass procedures impact the market growth in the region, positively.

The Asia Pacific perfusion market is emerging as a profitable market, worldwide. Factors such as the proliferating healthcare sector along with the flourishing medical tourism market in highly populated countries like India and China drive the regional market. Also, the rising cases of patients suffering from coronary diseases, increasing geriatric populace and spreading awareness about healthcare foster the growth of the regional market.

Overview

The perfusion market is growing pervasively mainly attributing to the increasing prevalence of chronic diseases associated with lungs, heart, liver, and kidneys which are the result of changing lifestyle. Over the last three decades, perfusions have evolved hugely, demonstrating remarkable advances which are leading to driving the growth of the market. Simultaneously, there has been a remarkable growth in the awareness about related surgeries required to managing these diseases which, as a result, are escalating the market on the global platform.

According to an eminent research firm, Market Research Future (MRFR) the perfusion market is growing steadily, globally, and is expected to continue growing in the years to come. In its recently published study report MRFR asserts that the global perfusion market will garner a valuation of USD 1,527 MN by 2023 posting approximately 4.1% CAGR throughout the assessment period (2017-2023).

Additionally factors such as the increasing population and urbanization led by the improving economic conditions that are increasingly expanding the access to the quality healthcare expanding the market size of profusion. Moreover, rising cases of lifestyle diseases, smoking, and consumption of alcohol which eventually lead to increasing the cases of organ failure are boosting the growth of the market.

On the other hand, factors such as the lack of awareness regarding perfusion systems in developing countries are impeding market growth.

Industry/Innovation/Related News:

Circle Cardiovascular Imaging Inc. (Canada), leading global company developing analytical software for the cardiac imaging community announced the acquisition of Corstem Inc.(Canada), machine learning and artificial intelligence software developer specialized in cardiac imaging analysis to introduce automatic, fully-quantitative myocardial perfusion in cvi42.

The acquisition will further expand Circle’s innovative technology and product offerings with Corstem’s technologies integrated into Circle’s core product – cvi42, including an automatic and comprehensive solution for fully-quantitative myocardial perfusion.

Patient Temperature Monitoring Market Research Report - Forecast to 2023 | MRFR

Positron Emission Tomography Devices Market Research Report - Forecast to 2023 | MRFR

Hair Removal Devices Market Research Report - Forecast to 2023 | MRFR

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com